Johnson & Johnson launches two new aspiration catheters for ischemic stroke treatment

Johnson & Johnson recently announced the U.S. launch of CEREGLIDE 42 and CEREGLIDE 57 aspiration catheters, along with the INNERGLIDE 7 delivery aid, as the latest additions to its aspiration-first stroke portfolio. These devices complete the CEREGLIDE family and are designed to help physicians reach and remove distal clots more consistently, while simplifying procedural decisions and supporting performance across a broad range of ischemic stroke cases.

“We designed this multi-axial system to address procedural challenges physicians face when treating stroke,” says Christian Cuzick, worldwide president, Neurovascular, MedTech, Johnson & Johnson. “With this expanded portfolio, we’re simplifying decisions, enhancing consistency across device sizes, and reinforcing our commitment to helping improve patient outcomes.”

CEREGLIDE 42 and CEREGLIDE 57 are built with a proprietary, variable-stiffness construction that provides flexible1 distal navigation and supportive proximal control. Both catheters are intended to integrate seamlessly into existing neurointerventional workflows, offering:

• Hydrophilic coating for reduced friction in tortuous anatomy
• Radiopaque (based on benchmark testing) tip marker for fluoroscopic visibility
• Easily track to the M2 with TruCourse Technology

“Accessing distal occlusions remains one of the biggest technical challenges we face, especially in smaller or more tortuous vessels,” says Ameer E. Hassan, DO, FAHA, FSVIN, Neuroscience Institute, Valley Baptist Medical Center, Harlingen, Texas. “In my experience, CEREGLIDE 42 and 57 track reliably while maintaining strong proximal support, even over multiple passes. That balance of flexibility and control gives me greater confidence when performing aspiration-first thrombectomy in more complex anatomy.”

INNERGLIDE 7 is a delivery aid designed to support the advancement of large-bore catheters such as CEREGLIDE 71 to distal clot locations. It features a hydrophilic-coated shaft, 1.5cm soft distal tip, and compatibility with 0.024" guidewires, offering added control and support during complex device delivery.

“Reaching the M2 segment with large-bore aspiration systems can be technically demanding,” says Dr. Hassan. “INNERGLIDE 7 provides the additional support needed to consistently deliver CEREGLIDE 71 into more distal targets with smoother navigation and less resistance. I am a firm believer in delivery catheter technology like INNERGLIDE.”

The CEREGLIDE family of catheters now includes 42, 57, and 71 aspiration catheters, providing a range of catheters designed for performance, consistency, and compatibility across procedures.